Clinical Trials Logo

Adenoma clinical trials

View clinical trials related to Adenoma.

Filter by:

NCT ID: NCT02940977 Recruiting - Prostatic Neoplasms Clinical Trials

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

Start date: October 1, 2016
Phase:
Study type: Observational

1. To elucidate the role of CTC detection in the evaluation of risk level in PCa patients, and establish a mathematic model for predicting the pathological status. 2. To explore the possible subtle change in CTC condition after radical prostatectomy.

NCT ID: NCT02940392 Completed - Clinical trials for Benign Prostatic Hyperplasia

Rezum FIM Optimization Study

Rezum FIM
Start date: March 19, 2012
Phase: N/A
Study type: Interventional

Evaluate the effect of the NxThera BPH Rezum System on prostate tissue in subjects suffering from LUTS symptoms secondary to benign prostatic hyperplasia (BPH).

NCT ID: NCT02935049 Recruiting - Colorectal Adenoma Clinical Trials

Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid Technique

HYBRID ESD
Start date: October 2016
Phase: N/A
Study type: Observational

For tough colic resection, evaluation of our practice for these lesions unresectable in monoblock and evaluation of the contribution of the hybrid technique EMR (mucosectomy dissection) /ESD (submucosal dissection)

NCT ID: NCT02886000 Recruiting - Colorectal Adenoma Clinical Trials

Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps

Start date: June 2014
Phase: Phase 2
Study type: Interventional

This randomized phase II clinical trial studies how well MUC1 peptide-poly-ICLC adjuvant vaccine works in treating patients with newly diagnosed advanced colon polyps (adenomatous polyps). Adenomatous polyps are growths in the colon that may develop into colorectal cancer over time. Vaccines made from peptides may help the body build an effective immune response to kill polyp cells. MUC1 peptide-poly-ICLC adjuvant vaccine may also prevent the recurrence of adenomatous polyps and may prevent the development of colorectal cancer.

NCT ID: NCT02885987 Withdrawn - Colonic Polyps Clinical Trials

Use of Accessory Device AmplifEYE During Average Risk Screening Colonoscopy to Increase Adenoma Detection Rate

Start date: August 3, 2017
Phase: N/A
Study type: Interventional

The purpose of this investigator-initiated study is to determine whether the use of an accessory device called AmplifEYE can improve colonoscopy quality in patients who are undergoing average risk colorectal cancer screening. Primary end point is adenoma detection rates.

NCT ID: NCT02880748 Recruiting - Adenoma Clinical Trials

Effect of Water Exchange Method on Adenoma Miss Rates in Patients Undergoing Selective Polypectomy

Start date: August 2016
Phase: N/A
Study type: Interventional

Patients with colorectal adenomas are suggested to receive polypectomy. A substantial number of adenomas may be missed in patients with polyps found by previous colonoscopy. And water exchange (WE) method may increase the detection of missed adenoma compared with traditional air insufflation (AI) colonoscopy. The investigators aim to investigate whether water exchange colonoscopy method, compared with air insufflation method, can improve the detection of missed adenomas in patients undergoing selective polypectomy.

NCT ID: NCT02876133 Recruiting - Colon Cancer Clinical Trials

Narrow Band Imaging Versus White Light for Colonoscopy Serrate Lesions Detection

Start date: November 2016
Phase: N/A
Study type: Interventional

Colorectal cancer (CRC) is a leading cause of cancer death and its' incidence is rising in most European countries. Colonoscopy has been shown to reduce CRC incidence, however its effectiveness depends on the sensitivity to detect pre-malignant lesions. Our aim is to evaluate narrow band imaging (NBI) during colonoscopy and serum miRNAs as novel tools for the early detection of colonic sessile serrated lesions (SSL). The investigators will perform a multicenter-randomized-controlled-trial to study the role of NBI in SSL detection.

NCT ID: NCT02867826 Not yet recruiting - Clinical trials for Ampulla of Vater Intestinal-Type Adenoma

The Use of Cap-assisted Forward Viewing Endoscopy for Examination of the Ampulla of Vater

Start date: August 2016
Phase: Phase 2
Study type: Interventional

The aim of this study is to compare the visualization rates of the ampulla of Vater using forward- viewing endoscopes with or without cap attached to the distal end in the same patient.

NCT ID: NCT02865382 Not yet recruiting - Colonic Polyps Clinical Trials

Detection of Colorectal Adenoma by Optical Enhancement Technology vs. High-Definition Colonoscopy

Start date: September 2016
Phase: N/A
Study type: Interventional

Optical Enhancement Technology might be superior to the conventional HD-WL in detecting colorectal adenomas

NCT ID: NCT02859883 Completed - Clinical trials for Ampulloma of the Accessory Papilla

Evaluation of Oesogastroduodenoscopy With Vision to 245 ° (Full Spectrum Endoscopy) to View the Main Disc and Accessory

FUSE-TM-Duo
Start date: March 18, 2015
Phase: N/A
Study type: Observational

The monitoring and prognosis of patients with familial polyposis adenomatous rests on analysis of the transitional mucosa at the anal margin and especially on the tracking, characterization and resection of lesions of dysplasia type of high grade at the duodenal level, after total proctocolectomy. Currently, endoscopes with axial or lateral vision are used. The FUSE technology allows the simplification or even the improvement of patient surveillance with a 245° vision (versus150° in case of classical gastroscope). The use of a second screen to enlarge the field of view may allow both analysis of duodenum and the main and accessory papilla with one single endoscope and to decrease the number of omitted lesions .